| Mepha Pharma AG - Abacavir-Lamivudin-Mepha 600 mg/300 mg, Filmtabletten | | 67064 | | 01 | | Abacavir-Lamivudin-Mepha 600 mg/300 mg | | Filmtabletten | | J05AR02 | | Lamivudine and Abacavir | | 04.07.2018 | | |
| | Composition | | abacavirum 600 mg, lamivudinum 300 mg, cellulosum microcristallinum, hydroxypropylcellulosum, carboxymethylamylum natricum A, magnesii stearas, Überzug: hypromellosum, macrogolum 4000, polysorbatum 80, E 171, E 172 (flavum), E 172 (rubrum), pro compresso obducto corresp. natrium 3.276 mg. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Abacavir | 600 mg | | Lamivudine | 300 mg |
| | BAG: Active Agent | Dose |
|---|
| Lamivudine | 300 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| (Flavum) | | | | (Rubrum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hydroxypropylcellulosum | | | | Hypromellosum | | Überzug | | Macrogol | 4000 | | | Magnesii Stearas | | | | Polysorbatum 80 | | | | Pro Compresso Obducto | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 30 | 232.22 | 268.95 | A | | Yes |
|
|
